Skip to main content

Life Sciences Industry Executive Roundtable

Mintz Levin


Date: April 22, 2015

Time: 3:30AM - 6:00AM

Location: San Diego, CA


  • Raising Capital to Fund Your Organization
  • Navigating the IPO and Alternative IPO Processes
Please join CohnReznick and Mintz Levin, along with an exclusive group of Life Sciences executives, for breakfast and engaging conversation to discuss many of the critical issues related to capital formation and the IPO process.


Discussion topics

Raising Capital to Fund Your Organization
When it comes to raising capital, there are a wide variety of potential sources - some traditional and some a bit unconventional. Learn about various capital raising options including convertible debt, equity and preferred equity, and opportunities with venture capital funding. This panel will include key executives from Life Sciences organizations who have utilized these funding alternatives and a Venture Capital Firm focused in the Life Sciences industry.

Navigating the IPO and Alternative IPO Processes
Planning and executing a successful IPO, reverse merger, or Form 10 is a challenging undertaking, especially for CEOs and CFOs who are responsible for many aspects of the transaction. Understanding the necessary steps and the roles that advisors play within the process is essential to ensure that an organization is optimizing its approach from a legal, SEC compliance, and accounting perspective. Our panel of experts will share insights and observations based upon their involvement with recent IPOs, reverse mergers, and Form 10 transactions. Legal, regulatory (SEC) and accounting perspectives will be highlighted including a discussion of key opportunities arising from the JOBS Act.



7:30 - 8:00 AM
Arrivals and Breakfast
8:00 - 8:45 AM
Raising Capital to Fund Your Organization – IPO Reverse Merge Venture Capital Funding
8:45 - 9:00 AM
9:00 - 9:45 AM
Navigating the IPO and Alternative IPO Processes - Legal/SEC/Accounting


9:45 - 10:00 AM
Closing Remarks



Space is limited, so register today.
Brittney Broberg


Jeremy Glaser Headshot

Jeremy D. Glaser


Jeremy D. Glaser is Co-chair of Mintz's Venture Capital & Emerging Companies Practice. He has over three decades of experience guiding life sciences and technology companies in growth and financing strategies, including public offerings, financings, mergers and acquisitions, and SEC compliance.
Professional Cropped Hicks William Mintz

William C. Hicks


William C. Hicks is Co-chair of the Life Sciences Practice Group at Mintz. He has extensive experience representing issuers, investors, and investment banks in structuring and executing IPOs, cross-over investments, alternative public offerings, including APOs, reverse mergers and Form 10 transactions, follow-on public offerings, CMPOs, registered directs, PIPEs, and private placements. His clients include hedge funds, venture capital firms, and private equity firms in customized investments in public companies, including structured PIPEs and registered directs. Bill also represents public companies in public and private financings, SEC compliance, corporate governance, and general counseling.